Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance.

× No keyword cloud information.

18 in total

Review 1. Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

Authors: Martyn K White; Ilker K Sariyer; Jennifer Gordon; Serena Delbue; Valeria Pietropaolo; Joseph R Berger; Kamel Khalili
Journal: Rev Med Virol Date: 2015-12-14 Impact factor: 6.989

2. Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

Authors: J Hodel; O Outteryck; S Verclytte; V Deramecourt; A Lacour; J-P Pruvo; P Vermersch; X Leclerc
Journal: AJNR Am J Neuroradiol Date: 2015-08-27 Impact factor: 3.825

Review 3. Monoclonal antibodies as disease modifying therapy in multiple sclerosis.

Authors: Erin E Longbrake; Becky J Parks; Anne H Cross
Journal: Curr Neurol Neurosci Rep Date: 2013-11 Impact factor: 5.081

Review 4. Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs.

Authors: Emanuele D'Amico; Aurora Zanghì; Carmela Leone; Hayrettin Tumani; Francesco Patti
Journal: Drug Saf Date: 2016-12 Impact factor: 5.606

5. Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.

Authors: Cinzia Cordioli; Nicola De Rossi; Sarah Rasia; Giovanni Lodoli; Ruggero Capra
Journal: Neurol Sci Date: 2014-08-11 Impact factor: 3.307

6. Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?

Authors: Mike P Wattjes; Anke Vennegoor; Jop Mostert; Bob W van Oosten; Frederik Barkhof; Joep Killestein
Journal: J Neurol Date: 2014-04-06 Impact factor: 4.849

Review 7. Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.

Authors: Mark S Igra; David Paling; Mike P Wattjes; Daniel J A Connolly; Nigel Hoggard
Journal: Br J Radiol Date: 2017-04-26 Impact factor: 3.039

8. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.

Authors: Martijn T Wijburg; Iris Kleerekooper; Birgit I Lissenberg-Witte; Marlieke de Vos; Clemens Warnke; Bernard M J Uitdehaag; Frederik Barkhof; Joep Killestein; Mike P Wattjes
Journal: JAMA Neurol Date: 2018-07-01 Impact factor: 18.302

Review 9. Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?

Authors: Joachim Havla; Ingo Kleiter; Tania Kümpfel
Journal: Ther Clin Risk Manag Date: 2013-10-03 Impact factor: 2.423

10. Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.

Authors: Hans Lindå; Anders von Heijne
Journal: Front Neurol Date: 2013-02-18 Impact factor: 4.003